111 related articles for article (PubMed ID: 2524947)
1. Role of prolactin in age-related change in serum dehydroepiandrosterone sulphate concentrations.
Yamaji T; Ishibashi M; Takaku F; Teramoto A; Takakura K; Takami M; Fukushima T; Kamoi K
Acta Endocrinol (Copenh); 1989 May; 120(5):655-60. PubMed ID: 2524947
[TBL] [Abstract][Full Text] [Related]
2. Increased androgen secretion in patients with prolactinomas: the impact of altered HPA function.
Moria Y; Kortbawi R; El-Asmar N; Arafah BM
Pituitary; 2019 Apr; 22(2):170-178. PubMed ID: 30798438
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
4. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone sulphate in critical illness: effect of dopamine.
Van den Berghe G; de Zegher F; Wouters P; Schetz M; Verwaest C; Ferdinande P; Lauwers P
Clin Endocrinol (Oxf); 1995 Oct; 43(4):457-63. PubMed ID: 7586621
[TBL] [Abstract][Full Text] [Related]
6. Mass screening for hyperprolactinemia and prolactinoma in men.
Miyake A; Ikegami M; Chen CF; Arita N; Aono T; Tanizawa O; Yoshikawa T
J Endocrinol Invest; 1988 May; 11(5):383-4. PubMed ID: 3183301
[TBL] [Abstract][Full Text] [Related]
7. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
[TBL] [Abstract][Full Text] [Related]
8. Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link?
Perić B; Kruljac I; Šundalić S; Pećina HI; Jović A; Štefanović M; Butorac D; Vrkljan M
Endocr Res; 2016 Aug; 41(3):200-6. PubMed ID: 26864960
[TBL] [Abstract][Full Text] [Related]
9. Absence of suppressive effect of somatostatin on prolactin levels in patients with hyperprolactinemia.
Bronstein MD; Knoepfelmacher M; Liberman B; Marino R; Germek OA; Schally AV
Horm Metab Res; 1987 Jun; 19(6):271-4. PubMed ID: 2887502
[TBL] [Abstract][Full Text] [Related]
10. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
11. Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma.
Grottoli S; Gasco V; Broglio F; Baldelli R; Ragazzoni F; Gallenca F; Mainolfi A; Prodam F; Muccioli G; Ghigo E
J Clin Endocrinol Metab; 2006 Apr; 91(4):1595-9. PubMed ID: 16449338
[TBL] [Abstract][Full Text] [Related]
12. Anti-thyroid antibodies in patients with hyperprolactinemia.
Ishibashi M; Kuzuya N; Sawada S; Kitamura K; Kamoi K; Yamaji T
Endocrinol Jpn; 1991 Oct; 38(5):517-22. PubMed ID: 1843271
[TBL] [Abstract][Full Text] [Related]
13. The relationship between prolactin, dehydroepiandrosterone sulphate and testosterone in normally menstruating females.
Wathen NC; Perry L; Hodgkinson S; Chard T
Acta Endocrinol (Copenh); 1985 Jun; 109(2):173-5. PubMed ID: 3160207
[TBL] [Abstract][Full Text] [Related]
14. The effect of hyperprolactinemia on the diurnal variation of adrenal androgens.
Clapp DH; Wiebe RH
Fertil Steril; 1983 Jun; 39(6):749-52. PubMed ID: 6221947
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex.
Carlström K; Brody S; Lunell NO; Lagrelius A; Möllerström G; Pousette A; Rannevik G; Stege R; von Schoultz B
Maturitas; 1988 Dec; 10(4):297-306. PubMed ID: 2976116
[TBL] [Abstract][Full Text] [Related]
16. Basal serum dehydroepiandrosterone sulphate concentration does not predict the cortisol response to provocative testing.
Littley MD; Pollock A; Kane J; Shalet SM
Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():557-61. PubMed ID: 2150469
[TBL] [Abstract][Full Text] [Related]
17. Coexisting Prolactinoma and Primary Aldosteronism: Is There a Pathophysiological Link?
Williams TA; Dietz AS; Theodoropoulou M; Riester A; Fischer E; Burrello J; Treitl M; Geyer L; Veglio F; Bidlingmaier M; Schopohl J; Beuschlein F; Mulatero P; Reincke M
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1262-9. PubMed ID: 26176803
[TBL] [Abstract][Full Text] [Related]
18. Relation of RANKL and OPG Levels with Bone Resorption in Patients with Acromegaly and Prolactinoma.
Ozer FF; Dagdelen S; Erbas T
Horm Metab Res; 2018 Jul; 50(7):562-567. PubMed ID: 29895074
[TBL] [Abstract][Full Text] [Related]
19. Immunoradiometric assay for prolactin in serum and tissue--comparison with radioimmunoassay.
Ohnami S; Nakata H; Eto S
Radioisotopes; 1990 Sep; 39(9):393-5. PubMed ID: 2236664
[TBL] [Abstract][Full Text] [Related]
20. A predictive algorithm for evaluating elevated serum prolactin in patients with a sellar mass.
Cheng JS; Salinas R; Molinaro A; Chang EF; Kunwar S; Blevins L; Aghi MK
J Clin Neurosci; 2015 Jan; 22(1):155-60. PubMed ID: 25481269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
